Doç. Dr.
Dr David J Pinato
Oncology
- 🇬🇧
- 🇮🇹
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Dr David J Pinato
Dr David J Pinato is a highly esteemed clinician scientist and consultant medical oncologist. They are committed to providing exceptional care and advancing the field of cancer treatment through innovative research. Their work focuses on developing and implementing novel experimental anticancer therapies, with a particular interest in anti-cancer immunotherapy. Dr Pinato is passionate about translating scientific discoveries into tangible benefits for patients. Their expertise lies in understanding the complex mechanisms of cancer and developing personalised treatment strategies. Dr Pinato is dedicated to delivering compassionate and patient-centred care, ensuring each individual receives the most effective treatment options available.
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) ·
#-934436
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Oncology
#EB-3F0EE53B
Renewal due 2032
Verify with issuerMalpractice cover
AmTrust Europe
2,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2011–2017
MD · Medicine and Surgery
Universidad Complutense de Madrid
-
2017–2021
Residency · Oncology
Universitat de Barcelona
Career & appointments
-
2021-09–2022-08
Junior consultant
Universidad Complutense de Madrid Teaching Hospital — Oncology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
554 |
| Annual physical exam | 99395 |
1,348 |
| Vaccination administration | 90471 |
164 |
| Minor procedure (skin) | 17110 |
1,259 |
Patient reviews
See all 1193"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2022
- national college of family doctors — Member · since 2022
- European Union of Medical Specialists (UEMS) — Member · since 2022
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Research & publications
h-index: 10 · i10: 11
Selected publications
-
Long-term follow-up of Oncology across
DOI: 10.8768/euroclin.2026.0 · cited by 194
-
Validation of clinical scoring in Oncology
DOI: 10.4327/euroclin.2025.1 · cited by 104
-
Long-term follow-up of Oncology across
DOI: 10.2869/euroclin.2024.2 · cited by 62
Show full research record
Additional publications
-
Validation of clinical scoring in Oncology
Invited talks
- Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
- Single-centre experience in Oncology · National Society Meeting · · 2023
Articles by Dr David J Pinato
Frequently asked
01. Do you accept new patients?
Dr David J Pinato is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English, Italian.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
Please use the booking flow to enter your insurance — we verify and confirm before your slot.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.